<DOC>
	<DOCNO>NCT00253890</DOCNO>
	<brief_summary>The purpose study : 1. evaluate relationship subjective complaint sleep objective measure sleep quality , measure polysomnography , 2. evaluate efficacy trazodone , compare placebo , individual early methadone maintenance .</brief_summary>
	<brief_title>Insomnia Drug Relapse Risk</brief_title>
	<detailed_description>Individuals new methadone maintenance ask participate 6-month , double-blind , randomize control trial . All participant complete baseline interview , medical screen follow-up interview 1 , 3 6-months post-baseline . These interview take approximately 60 minute , survey various area participant ' experience , include basic demographic information , mood , sleep substance use area . All participant also ask complete 2-night sleep monitoring time baseline interview 1-month follow-up interview . Participants also receive study medication ; half participant receive placebo medication , half receive Trazodone , widely-prescribed , well-tolerated , low side-effect medication . Neither participant study staff know medication participant take participant actively enrol study . This information available participant end his/her study participation .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Trazodone</mesh_term>
	<criteria>Recent methadone maintenance enrollment Sleep complaint measure Pittsburgh Sleep Quality Index ( PSQI ) No medical contraindication trazodone Methadone maintenance enrollment recent No sleep complaint measure PSQI Medical contraindication trazodone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>sleep quality</keyword>
	<keyword>methadone</keyword>
	<keyword>substance use</keyword>
</DOC>